Long-term follow-up of study participants from prophylactic HIV vaccine clinical trials in Africa

Long-term safety is critical for the development and later use of a vaccine to prevent HIV/AIDS. Likewise, the persistence of vaccine-induced antibodies and their impact on HIV testing must be established. IAVI has sponsored several Phase I and IIA HIV vaccine trials enrolling healthy, HIV-seronegat...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Schmidt, Claudia, Jaoko, Walter, Omosa-Manyonyi, Gloria, Kaleebu, Pontiano, Mpendo, Juliet, Nanvubya, Annet, Karita, Etienne, Bayingana, Roger, Bekker, Linda-Gail, Chomba, Elwyn, Kilembe, William, Nchabeleng, Maphoshane, Nyombayire, Julien, Stevens, Gwynn, Chetty, Paramesh, Lehrman, Jennifer, Cox, Josephine, Allen, Susan, Dally, Len, Smith, Carol, Fast, Patricia E
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Landes Bioscience 2014
Konular:
Research Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4130282/
https://ncbi.nlm.nih.gov/pubmed/24374365
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.27559
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller